Send me a link:

*Text messaging rates may apply.

 Dow Down0.42% Nasdaq Down0.39%

Elite Pharmaceuticals, Inc. (ELTP)

-OTC BB
0.31 Down 0.00(1.58%) 4:00PM EDT
Company EventsGet Company Events for:
Upcoming Events 
DateEventReminder
No Upcoming Events
Recent Events 
DateEvent
30-Jun-14ELITE PHARMACEUTICALS INC /NV/ Files SEC form 10-K, Annual Report
11-Jun-14ELITE PHARMACEUTICALS INC /NV/ Files SEC form 8-K, Termination of a Material Definitive Agreement, Financial Statemen
23-May-14ELITE PHARMACEUTICALS INC /NV/ Files SEC form 8-K, Submission of Matters to a Vote of Security Holders, Financial Sta
14-Apr-14ELITE PHARMACEUTICALS INC /NV/ Files SEC form 8-K, Unregistered Sale of Equity Securities, Financial Statements and E
18-Mar-14ELITE PHARMACEUTICALS INC /NV/ Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year
14-Feb-14ELITE PHARMACEUTICALS INC /NV/ Files SEC form 10-Q, Quarterly Report
7-Feb-14ELITE PHARMACEUTICALS INC /NV/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of E
26-Nov-13ELITE PHARMACEUTICALS INC /NV/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements a
14-Nov-13ELITE PHARMACEUTICALS INC /NV/ Files SEC form 10-Q, Quarterly Report
16-Oct-13ELITE PHARMACEUTICALS INC /NV/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements a
8-Oct-13ELITE PHARMACEUTICALS INC /NV/ Files SEC form 8-K, Entry into a Material Definitive Agreement
18-Sep-13ELITE PHARMACEUTICALS INC /NV/ Files SEC form 8-K, Other Events, Financial Statements and Exhibits
13-Sep-13ELITE PHARMACEUTICALS INC /NV/ Files SEC form 8-K, Unregistered Sale of Equity Securities
23-Aug-13ELITE PHARMACEUTICALS INC /NV/ Files SEC form 8-K, Entry into a Material Definitive Agreement
14-Aug-13ELITE PHARMACEUTICALS INC /NV/ Files SEC form 10-Q, Quarterly Report
6-Aug-13ELITE PHARMACEUTICALS INC /NV/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements a
5-Aug-13ELITE PHARMACEUTICALS INC /NV/ Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Change in Dire